Loading…
Aptorum Group Ltd is projected to rise to $1.23 by 2027, a +75% move from its current price of $0.70. APM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 6 | $0.6143 | $0.7002 | $0.7981 | +0.02% |
| Aug 7 | $0.582 | $0.7003 | $0.8427 | +0.05% |
| Aug 8 | $0.5584 | $0.7005 | $0.8787 | +0.07% |
| Aug 9 | $0.5393 | $0.7007 | $0.9103 | +0.10% |
| Aug 10 | $0.523 | $0.7008 | $0.9391 | +0.12% |
| Aug 11 | $0.5088 | $0.701 | $0.9659 | +0.14% |
| Aug 12 | $0.496 | $0.7012 | $0.9912 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.496 | $0.7012 | $0.9912 | +0.17% |
| Week 2 | $0.4304 | $0.7023 | $1.15 | +0.33% |
| Week 3 | $0.3862 | $0.7035 | $1.28 | +0.50% |
| Week 4 | $0.3526 | $0.7047 | $1.41 | +0.67% |
| Week 5 | $0.3255 | $0.7058 | $1.53 | +0.83% |
| Week 6 | $0.3028 | $0.707 | $1.65 | +1.00% |
| Week 7 | $0.2834 | $0.7082 | $1.77 | +1.17% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aptorum Group Limited is a clinical stage biopharmaceutical company that, through its subsidiaries, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline includes SACT-1, a repurposed drug candidate in phase 1 to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule in phase 1 for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa; SACT-COV19, a repurposed small molecule in preclinical trial for the treatment of coronavirus disease; SACT-2 and SACT-3; ALS-1, a small molecule in preclinical trial to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-2/3, a small molecule in preclinical trial for the treatment of gram+ve bacterial infections.
The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Aptorum Group Limited trades in the healthcare sector and has a current price of $0.6924 with a market capitalization of $5.64M, ranking 5175 by market cap. The near-term technical setup is bearish, as reflected by a 30-day picture that shows RSI14 at 30, with a 50-day simple moving average of $0.8625 and a 200-day simple moving average of $1.08. The stock sits at a support level of $0.692 and faces resistance at $1.17, with a 30-day price range from $0.4973 to $0.964.
The longer-term outlook is captured in a year-by-year forecast spanning 2026 through 2050, with and average price trajectory that includes 2026 at $0.6924, 2029 at $0.8389, 2030 at $0.9794, 2040 at $1.12, and 2050 at $2.49. Max forecasts run to $1.67 in 2030 and reach $5.73 by 2050, with corresponding ROI figures noted for each year. Overall, the forecast presents a path toward higher prices in the longer term, albeit with periods of declining averages in the nearer years and notable volatility.
A major floor 1.1% below — a decisive break under it would weaken the trend.
Support has flipped 900.0% overhead — reclaiming it would be bullish.
The nearest ceiling, 1262.9% above — a clean break opens room to run.
A major ceiling 2051.7% above — clearing it would confirm fresh momentum.
Key APM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of APM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.77 | Sell | $8.07 | Sell |
| MA 10 | $6.18 | Sell | $6.63 | Sell |
| MA 20 | $3.48 | Sell | $4.69 | Sell |
| MA 50 | $1.93 | Sell | $2.72 | Sell |
| MA 100 | $1.41 | Sell | $1.90 | Sell |
| MA 200 | $1.30 | Sell | $1.54 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 83.37 | Sell |
| Stoch RSI (14) | 78.24 | Neutral |
| CCI (20) | 93.69 | Neutral |
| Williams %R (14) | -12.77 | Info |
| MACD (12,26,9) | 0.73 | Buy |
| ROC (12) | 971.34 | Buy |
| Bollinger %B (20,2) | 0.83 | Neutral |
| Stochastic %K (14) | 87.23 | Sell |
| TRIX (15) | 13.86 | Buy |
| Awesome (5,34) | 6.35 | Buy |
| Ultimate (7,14,28) | 87.35 | Sell |
| Momentum (10) | 7.60 | Buy |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 9.53 | Sell |
| ADX (14) | 41.07 | Buy |
| ATR (14) | 0.52 | Info |
In the near term, the technical picture remains bearish. The RSI14 is 30, indicating modest momentum; the stock trades below the SMA50 of $0.8625 and well below the SMA200 of $1.08. The current price sits at a key support level of $0.692, with resistance at $1.17.
Over the last 30 days, the price has fluctuated between a low of $0.4973 and a high of $0.964, highlighting a confined but choppy range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.70 | $0.70 | $1.06 | 0% | Neutral | |
| $0.8071 | $1.23 | $2.02 | +75% | Bullish | |
| $0.9342 | $1.58 | $2.83 | +125% | Bullish | |
| $1.02 | $1.89 | $3.62 | +170% | Bullish | |
| $1.04 | $2.11 | $4.25 | +201% | Bullish | |
| $0.9925 | $2.18 | $4.60 | +212% | Bullish | |
| $1.03 | $2.29 | $5.02 | +227% | Bullish | |
| $1.20 | $2.67 | $6.07 | +282% | Bullish | |
| $2.01 | $4.46 | $10.26 | +537% | Bullish | |
| $2.40 | $5.33 | $12.25 | +661% | Bullish | |
| $3.42 | $7.61 | $17.50 | +987% | Bullish | |
| $8.22 | $18.26 | $42.01 | +25.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.70 | $0.70 | $0.8668 | +0.00% |
| September 2026 | $0.5214 | $0.6525 | $0.8627 | -6.79% |
| October 2026 | $0.5594 | $0.7153 | $0.9737 | +9.63% |
| November 2026 | $0.5942 | $0.7735 | $1.08 | +8.13% |
| December 2026 | $0.563 | $0.745 | $1.06 | -3.68% |
Click any year to see its month-by-month APM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect APM to range from $0.70 to $1.06 through 2026. The $0.70 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The APM price prediction for 2027 points to an average of $1.23 (low $0.8071, high $2.02) — a potential gain of +75% on today's $0.70. Momentum favours further upside here.
In 2028, APM is projected to trade between $0.9342 and $2.83, averaging $1.58 — a potential gain of +125% from today's $0.70. That is up +29% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Aptorum Group Ltd's 2029 outlook centres on $1.89, within a $1.02 to $3.62 range. That is up +20% on the projected 2028 average. That marks a +170% change versus current levels. Momentum favours further upside here.
By 2030, APM could reach as high as $4.25, with a base case around $2.11 and support toward $1.04 — roughly +201% from $0.70. Buyers look set to stay in control over this stretch.
Expect APM to range from $0.9925 to $4.60 through 2031. The $2.18 average target implies a +212% move from current prices. That is up +4% on the projected 2030 average. Momentum favours further upside here.
The APM price prediction for 2032 points to an average of $2.29 (low $1.03, high $5.02) — a potential gain of +227% on today's $0.70. Buyers look set to stay in control over this stretch.
In 2033, APM is projected to trade between $1.20 and $6.07, averaging $2.67 — a potential gain of +282% from today's $0.70. That is up +17% on the projected 2032 average. Momentum favours further upside here.
Aptorum Group Ltd's 2034 outlook centres on $4.46, within a $2.01 to $10.26 range. That is up +67% on the projected 2033 average. That marks a +537% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, APM could reach as high as $12.25, with a base case around $5.33 and support toward $2.40 — roughly +661% from $0.70. Momentum favours further upside here.
Expect APM to range from $3.42 to $17.50 through 2040. The $7.61 average target implies a +987% move from current prices. That is up +43% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The APM price prediction for 2050 points to an average of $18.26 (low $8.22, high $42.01) — a potential gain of +25.1x on today's $0.70. Momentum favours further upside here.
Investing $1,000 in APM today (≈ 1,428.571429 APM) could be worth
$26,092.06
+$25,092.06 (+2509%) by 2050 · US Dollar
Based on the average projected APM price of $18.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in APMwould be worth at today's price.
$1,000 invested in APM on Jul 28, 2025 (≈ 621.118007 APM) would be worth
$434.78
-$565.22 (-56.5%) today · 0.43× · US Dollar
Based on a APM entry price of $1.61 vs. today's $0.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.59 | $81.49 | -91.9% |
| 1 month ago | $0.774 | $904.39 | -9.6% |
| 3 months ago | $0.877 | $798.18 | -20.2% |
| 6 months ago | $0.85 | $823.53 | -17.6% |
| 1 year ago | $1.61 | $434.78 | -56.5% |
| All time (5.0y) ago | $26 | $26.92 | -97.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our APM forecast.
Our base-case forecast reaches $1.40 around 2028.
Implied market cap at $1.40: $888.55K
The multi-year forecast shows a mixed start followed by a bullish tilt in the longer horizon. For 2029 the avg is $0.8389 with a max of $1.37 and ROI of 21.2%, signaling bullish sentiment. By 2030 the avg rises to $0.9794 with a max of $1.67 and ROI of 41.5%, remaining bullish.
The outlook strengthens further into 2040 with an avg of $1.12 and a max of $2.40, ROI 62.2%, and remains bullish into 2050 with an avg of $2.49 and a max of $5.73, ROI 259.7%. These are estimates, not guarantees, and reflect substantial long‑term upside alongside ongoing volatility, underscored by an annualized volatility figure of 100%.
Tap a question to reveal the answer.
In 2030, the forecast shows min $0.6205, avg $0.9794, max $1.67 with ROI 41.5% and sentiment BULLISH.
The forecast suggests mixed early years (e.g., 2026 neutral with ROI 0% and 2027/2028 negative), followed by bullish prospects in 2029–2050 (e.g., 2030 ROI 41.5%, 2050 ROI 259.7%). However these are estimates, not guarantees, and volatility is high.
Yes. The 2050 forecast includes a max of $5.73 with ROI 259.7% and sentiment BULLISH.
Current price is $0.6924 and market capitalization is $5.64M.
The 30-day range is $0.4973 to $0.964. Support is $0.692 and resistance is $1.17; RSI is 30 and sentiment is BEARISH.
Aptorum Group Ltd Community Discussion
0Share your Aptorum Group Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.